世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

グライコミックス市場(製品タイプ。製品タイプ:酵素、器具、キット、試薬、アプリケーション。診断、創薬・開発、腫瘍、免疫、その他、エンドユーザー。世界の産業分析、規模、シェア、成長、傾向、予測、2021年~2031年


Glycomics Market (Product Type: Enzymes, Instruments, Kits, and Reagents; Application: Diagnostics, Drug Discovery & Development, Oncology, Immunology, and Others; and End-user: Academic Research Institutes, Pharmaceutical and & Biotechnology Companies, and Contract Research Organizations) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

グライコミックス市場 - レポートの範囲 TMRの調査レポート「世界のグリコミックス市場」は、2021年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Transparency Market Research
トランスペアレンシーマーケットリサーチ
2021年11月16日 US$5,795
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
224 英語

 

サマリー

グライコミックス市場 - レポートの範囲

TMRの調査レポート「世界のグリコミックス市場」は、2021年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。2017年から2019年を過去年、2020年を基準年、2021年から2031年を予測期間とし、2017年から2031年までの世界のグリコミックス市場全体の市場収益を提供します。また、予測期間における世界のグリコミックス市場の複合年間成長率(CAGR)を記載しています。

本レポートは、広範な調査を経て作成されました。一次調査では、アナリストが業界のリーダーやオピニオンメーカーにインタビューを行うなど、大規模な調査活動を行いました。二次調査では、主要企業の製品資料、年次報告書、プレスリリース、記事、ジャーナル、関連文書などを参照し、世界のグリコミックス市場を理解しました。

二次調査には、インターネット上の情報源、政府機関の統計データ、ウェブサイト、業界団体も含まれます。アナリストは、世界のグリコミックス市場における様々な現象を研究するために、トップダウンアプローチも採用しています。

本レポートには、調査範囲に含まれる様々なセグメントの成長行動のスナップショットとともに、精緻なエグゼクティブサマリーが含まれています。さらに、世界のグリコミックス市場における競争力学の変化についても光を当てています。これらの指標は、既存の市場関係者だけでなく、世界のグリコミックス市場への参入に関心のある事業者にとっても貴重なツールとなります。次のセクションでは、世界のグリコミックス市場における主要なM&A、技術の進歩、関連する主要研究機関、主要な開発などのUSPに焦点を当てています。

本レポートでは、世界のグリコミックス市場の競争環境について掘り下げています。世界のグリコミックス市場で事業を展開する主要企業が特定され、各企業の特徴的な事業特性についてプロファイルされています。企業概要、財務状況、最近の開発、SWOTなどは、本レポートで紹介されている世界のグリコミックス市場におけるプレイヤーの属性の一部です。

グリコミックス市場レポートにおいて回答された主な質問

世界市場における主要なドライバー、阻害要因、機会は何か?
予測期間中、世界のグリコミックス市場の主要セグメントの収益シェア予測はどうなるのか?
2031年までに収益面で世界のグライコミクス市場をリードしそうなセグメントは何か?
プレイヤー間のM&Aはどのように世界のグリコミックス市場の範囲を広げているのか?
世界のグリコミックス市場におけるリーディングカンパニーはどこか?
グリコミックス市場 - 研究目的と研究アプローチ

世界のグリコミックス市場に関する包括的なレポートでは、まず市場の概要を説明し、次に本調査の範囲と目的について述べます。続いて、本調査の目的、グリコミックス市場の調査範囲において公認機関が定めた医療コンプライアンスについて詳しく解説しています。続いて、市場導入、市場ダイナミクス、世界のグリコミックス市場の概要が記載されており、世界のグリコミックス市場の成長に影響を与える市場ドライバー、阻害要因、トレンドについてのTMR分析が含まれています。さらに、グリコミックス市場のY-O-Yトレンドを理解するために、精巧な洞察によるY-O-Y分析が提供されています。グリコミックス市場レポートの次のセクションでは、世界市場における技術スナップショット、プロセス概要、著名なソフトウェアツール、主要な産業開発、規制シナリオ、償還シナリオを含むUSPにハイライトを当てます。

読みやすさを考慮して、レポートは章立てでまとめられ、各セクションはさらに小さな節に分けられています。レポート全体では、グラフや表が適切に配置され、網羅的に構成されています。主要セグメントの実績値と予測値を絵で表現することで、読者に視覚的にアピールしています。また、過去と予測期間終了時の主要セグメントの市場シェアの比較も可能です。

本レポートでは、世界のグリコミックス市場を製品タイプ、用途、エンドユーザー、地域の観点から分析しています。各基準における主要セグメントを詳細に調査し、2031年末時点の各セグメントにおける市場シェアを掲載しています。このような貴重な洞察は、市場関係者がグリコミックス市場への投資について十分な情報を得た上でビジネス上の意思決定を行うことを可能にします。


ページTOPに戻る


目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Glycomics Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Glycomics Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
5.3. Technological Advancements
6. Global Glycomics Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Enzymes
6.3.1.1. Glycosidases
6.3.1.2. Glycosyltransferases
6.3.1.3. Neuraminidases
6.3.1.4. Sialyltransferases
6.3.1.5. Others
6.3.2. Instruments
6.3.2.1. Antibody Arrays
6.3.2.2. HPLC
6.3.2.3. Lectin Arrays
6.3.2.4. MALDI-TOF
6.3.2.5. Other Glycomics Instruments
6.3.3. Kits
6.3.3.1. Glycan Labeling Kits
6.3.3.2. Glycan Purification Kits
6.3.3.3. Glycan Release Kits
6.3.3.4. Others
6.3.4. Reagents
6.3.4.1. Glycoproteins
6.3.4.2. Monosaccharides
6.3.4.3. Oligosaccharides
6.3.4.4. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global Glycomics Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Diagnostics
7.3.2. Drug Discovery & Development
7.3.3. Oncology
7.3.4. Immunology
7.3.5. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Glycomics Market Analysis and Forecast End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Academic Research Institute
8.3.2. Pharmaceutical & Biotechnology Companies
8.3.3. Contract Research Organizations
8.4. Market Attractiveness Analysis, by End-user
9. Global Glycomics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. North America Glycomics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Enzymes
10.2.1.1. Glycosidases
10.2.1.2. Glycosyltransferases
10.2.1.3. Neuraminidases
10.2.1.4. Sialyltransferases
10.2.1.5. Others
10.2.2. Instruments
10.2.2.1. Antibody Arrays
10.2.2.2. HPLC
10.2.2.3. Lectin Arrays
10.2.2.4. MALDI-TOF
10.2.2.5. Other Glycomics Instruments
10.2.3. Kits
10.2.3.1. Glycan Labeling Kits
10.2.3.2. Glycan Purification Kits
10.2.3.3. Glycan Release Kits
10.2.3.4. Others
10.2.4. Reagents
10.2.4.1. Glycoproteins
10.2.4.2. Monosaccharides
10.2.4.3. Oligosaccharides
10.2.4.4. Others
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Diagnostics
10.3.2. Drug Discovery & Development
10.3.3. Oncology
10.3.4. Immunology
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Academic Research Institute
10.4.2. Pharmaceutical & Biotechnology Companies
10.4.3. Contract Research Organizations
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Glycomics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Enzymes
11.2.1.1. Glycosidases
11.2.1.2. Glycosyltransferases
11.2.1.3. Neuraminidases
11.2.1.4. Sialyltransferases
11.2.1.5. Others
11.2.2. Instruments
11.2.2.1. Antibody Arrays
11.2.2.2. HPLC
11.2.2.3. Lectin Arrays
11.2.2.4. MALDI-TOF
11.2.2.5. Other Glycomics Instruments
11.2.3. Kits
11.2.3.1. Glycan Labeling Kits
11.2.3.2. Glycan Purification Kits
11.2.3.3. Glycan Release Kits
11.2.3.4. Others
11.2.4. Reagents
11.2.4.1. Glycoproteins
11.2.4.2. Monosaccharides
11.2.4.3. Oligosaccharides
11.2.4.4. Others
11.3. Market Value Forecast Application, 2017–2031
11.3.1. Diagnostics
11.3.2. Drug Discovery & Development
11.3.3. Oncology
11.3.4. Immunology
11.3.5. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Academic Research Institute
11.4.2. Pharmaceutical & Biotechnology Companies
11.4.3. Contract Research Organizations
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. U.K.
11.5.2. Germany
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Glycomics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Enzymes
12.2.1.1. Glycosidases
12.2.1.2. Glycosyltransferases
12.2.1.3. Neuraminidases
12.2.1.4. Sialyltransferases
12.2.1.5. Others
12.2.2. Instruments
12.2.2.1. Antibody Arrays
12.2.2.2. HPLC
12.2.2.3. Lectin Arrays
12.2.2.4. MALDI-TOF
12.2.2.5. Other Glycomics Instruments
12.2.3. Kits
12.2.3.1. Glycan Labeling Kits
12.2.3.2. Glycan Purification Kits
12.2.3.3. Glycan Release Kits
12.2.3.4. Others
12.2.4. Reagents
12.2.4.1. Glycoproteins
12.2.4.2. Monosaccharides
12.2.4.3. Oligosaccharides
12.2.4.4. Others
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Diagnostics
12.3.2. Drug Discovery & Development
12.3.3. Oncology
12.3.4. Immunology
12.3.5. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Academic Research Institute
12.4.2. Pharmaceutical & Biotechnology Companies
12.4.3. Contract Research Organizations
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Glycomics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Enzymes
13.2.1.1. Glycosidases
13.2.1.2. Glycosyltransferases
13.2.1.3. Neuraminidases
13.2.1.4. Sialyltransferases
13.2.1.5. Others
13.2.2. Instruments
13.2.2.1. Antibody Arrays
13.2.2.2. HPLC
13.2.2.3. Lectin Arrays
13.2.2.4. MALDI-TOF
13.2.2.5. Other Glycomics Instruments
13.2.3. Kits
13.2.3.1. Glycan Labeling Kits
13.2.3.2. Glycan Purification Kits
13.2.3.3. Glycan Release Kits
13.2.3.4. Others
13.2.4. Reagents
13.2.4.1. Glycoproteins
13.2.4.2. Monosaccharides
13.2.4.3. Oligosaccharides
13.2.4.4. Others
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Diagnostics
13.3.2. Drug Discovery & Development
13.3.3. Oncology
13.3.4. Immunology
13.3.5. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Academic Research Institute
13.4.2. Pharmaceutical & Biotechnology Companies
13.4.3. Contract Research Organizations
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Glycomics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Enzymes
14.2.1.1. Glycosidases
14.2.1.2. Glycosyltransferases
14.2.1.3. Neuraminidases
14.2.1.4. Sialyltransferases
14.2.1.5. Others
14.2.2. Instruments
14.2.2.1. Antibody Arrays
14.2.2.2. HPLC
14.2.2.3. Lectin Arrays
14.2.2.4. MALDI-TOF
14.2.2.5. Other Glycomics Instruments
14.2.3. Kits
14.2.3.1. Glycan Labeling Kits
14.2.3.2. Glycan Purification Kits
14.2.3.3. Glycan Release Kits
14.2.3.4. Others
14.2.4. Reagents
14.2.4.1. Glycoproteins
14.2.4.2. Monosaccharides
14.2.4.3. Oligosaccharides
14.2.4.4. Others
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Diagnostics
14.3.2. Drug Discovery & Development
14.3.3. Oncology
14.3.4. Immunology
14.3.5. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Academic Research Institute
14.4.2. Pharmaceutical & Biotechnology Companies
14.4.3. Contract Research Organizations
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix
15.2. Market Share Analysis, by Company, 2020
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. Agilent Technologies, Inc.
15.4.1.1. Company Description
15.4.1.2. Business Overview
15.4.1.3. Financial Overview
15.4.1.4. SWOT Analysis
15.4.2. Asparia Glycomics
15.4.2.1. Company Description
15.4.2.2. SWOT Analysis
15.4.3. Bruker Corporation
15.4.3.1. Company Description
15.4.3.2. Business Overview
15.4.3.3. Financial Overview
15.4.3.4. SWOT Analysis
15.4.4. Canadian Glycomics Network (GLYCONET)
15.4.4.1. Company Description
15.4.4.2. Business Overview
15.4.4.3. SWOT Analysis
15.4.5. Glyco Expression Technologies, Inc.
15.4.5.1. Company Description
15.4.5.2. SWOT Analysis
15.4.6. Glycodiag
15.4.6.1. Company Description
15.4.6.2. Business Overview
15.4.6.3. SWOT Analysis
15.4.7. Merck KGaA
15.4.7.1. Company Description
15.4.7.2. Business Overview
15.4.7.3. Financial Overview
15.4.7.4. SWOT Analysis
15.4.8. New England Biolabs
15.4.8.1. Company Description
15.4.8.2. Business Overview
15.4.8.3. SWOT Analysis
15.4.9. RayBiotech, Inc.
15.4.9.1. Company Description
15.4.9.2. SWOT Analysis
15.4.10. Shimadzu Corporation
15.4.10.1. Company Description
15.4.10.2. Business Overview
15.4.10.3. Financial Overview
15.4.10.4. SWOT Analysis
15.4.11. Thermo Fisher Scientific, Inc.
15.4.11.1. Company Description
15.4.11.2. Business Overview
15.4.11.3. Financial Overview
15.4.11.4. SWOT Analysis
15.4.12. Vector Laboratories
15.4.12.1. Company Description
15.4.12.2. Business Overview
15.4.12.3. SWOT Analysis
15.4.13. Glyde Bio, Inc.
15.4.13.1. Company Description
15.4.13.2. SWOT Analysis

 

ページTOPに戻る


 

Summary

Glycomics Market – Scope of Report

TMR’s report on the global glycomics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides the overall market revenue of the global glycomics market for the period 2017–2031, considering 2017 to 2019 as historical years, 2020 as the base year, and 2021 to 2031 as the forecast period. The report also provides the compound annual growth rate (CAGR) of the global glycomics market for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, articles, journals, and relevant documents to understand the global glycomics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a top-down approach to study various phenomena in the global glycomics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global glycomics market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global glycomics market. The next section of the global glycomics market report highlights the USPs, which include key mergers & acquisitions, technological advancements, major research institutes involved, and key developments in the global glycomics market.

The report delves into the competitive landscape of the global glycomics market. Key players operating in the global glycomics market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global glycomics market profiled in this report.

Key Questions Answered in Glycomics Market Report

What are the major drivers, restraints, and opportunities in the global market?
What will be the revenue share projections of key segments of the global glycomics market during the forecast period?
Which segment is likely to lead the global glycomics market in terms of revenue by 2031?
How mergers & acquisitions among players are widening the scope of the global glycomics market?
Which are the leading companies in the global glycomics market?
Glycomics Market – Research Objectives and Research Approach

The comprehensive report on the global glycomics market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study and healthcare compliances laid down by accredited agencies in the purview of research in the glycomics market. It is followed by market introduction, market dynamics, and an overview of the global glycomics market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the global glycomics market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the glycomics market. The next section of the glycomics market report highlights the USPs, which include technology snapshot, process overview, prominent software tools, key industry developments, regulatory scenario, and reimbursement scenario in the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global glycomics market in terms of product type, application, end-user, and region. Key segments under each criteria have been studied at length, and the market share of each of them at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investments in the glycomics market.



ページTOPに戻る


Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Glycomics Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Glycomics Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
5.3. Technological Advancements
6. Global Glycomics Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Enzymes
6.3.1.1. Glycosidases
6.3.1.2. Glycosyltransferases
6.3.1.3. Neuraminidases
6.3.1.4. Sialyltransferases
6.3.1.5. Others
6.3.2. Instruments
6.3.2.1. Antibody Arrays
6.3.2.2. HPLC
6.3.2.3. Lectin Arrays
6.3.2.4. MALDI-TOF
6.3.2.5. Other Glycomics Instruments
6.3.3. Kits
6.3.3.1. Glycan Labeling Kits
6.3.3.2. Glycan Purification Kits
6.3.3.3. Glycan Release Kits
6.3.3.4. Others
6.3.4. Reagents
6.3.4.1. Glycoproteins
6.3.4.2. Monosaccharides
6.3.4.3. Oligosaccharides
6.3.4.4. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global Glycomics Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Diagnostics
7.3.2. Drug Discovery & Development
7.3.3. Oncology
7.3.4. Immunology
7.3.5. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Glycomics Market Analysis and Forecast End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Academic Research Institute
8.3.2. Pharmaceutical & Biotechnology Companies
8.3.3. Contract Research Organizations
8.4. Market Attractiveness Analysis, by End-user
9. Global Glycomics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. North America Glycomics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Enzymes
10.2.1.1. Glycosidases
10.2.1.2. Glycosyltransferases
10.2.1.3. Neuraminidases
10.2.1.4. Sialyltransferases
10.2.1.5. Others
10.2.2. Instruments
10.2.2.1. Antibody Arrays
10.2.2.2. HPLC
10.2.2.3. Lectin Arrays
10.2.2.4. MALDI-TOF
10.2.2.5. Other Glycomics Instruments
10.2.3. Kits
10.2.3.1. Glycan Labeling Kits
10.2.3.2. Glycan Purification Kits
10.2.3.3. Glycan Release Kits
10.2.3.4. Others
10.2.4. Reagents
10.2.4.1. Glycoproteins
10.2.4.2. Monosaccharides
10.2.4.3. Oligosaccharides
10.2.4.4. Others
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Diagnostics
10.3.2. Drug Discovery & Development
10.3.3. Oncology
10.3.4. Immunology
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Academic Research Institute
10.4.2. Pharmaceutical & Biotechnology Companies
10.4.3. Contract Research Organizations
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Glycomics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Enzymes
11.2.1.1. Glycosidases
11.2.1.2. Glycosyltransferases
11.2.1.3. Neuraminidases
11.2.1.4. Sialyltransferases
11.2.1.5. Others
11.2.2. Instruments
11.2.2.1. Antibody Arrays
11.2.2.2. HPLC
11.2.2.3. Lectin Arrays
11.2.2.4. MALDI-TOF
11.2.2.5. Other Glycomics Instruments
11.2.3. Kits
11.2.3.1. Glycan Labeling Kits
11.2.3.2. Glycan Purification Kits
11.2.3.3. Glycan Release Kits
11.2.3.4. Others
11.2.4. Reagents
11.2.4.1. Glycoproteins
11.2.4.2. Monosaccharides
11.2.4.3. Oligosaccharides
11.2.4.4. Others
11.3. Market Value Forecast Application, 2017–2031
11.3.1. Diagnostics
11.3.2. Drug Discovery & Development
11.3.3. Oncology
11.3.4. Immunology
11.3.5. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Academic Research Institute
11.4.2. Pharmaceutical & Biotechnology Companies
11.4.3. Contract Research Organizations
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. U.K.
11.5.2. Germany
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Glycomics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Enzymes
12.2.1.1. Glycosidases
12.2.1.2. Glycosyltransferases
12.2.1.3. Neuraminidases
12.2.1.4. Sialyltransferases
12.2.1.5. Others
12.2.2. Instruments
12.2.2.1. Antibody Arrays
12.2.2.2. HPLC
12.2.2.3. Lectin Arrays
12.2.2.4. MALDI-TOF
12.2.2.5. Other Glycomics Instruments
12.2.3. Kits
12.2.3.1. Glycan Labeling Kits
12.2.3.2. Glycan Purification Kits
12.2.3.3. Glycan Release Kits
12.2.3.4. Others
12.2.4. Reagents
12.2.4.1. Glycoproteins
12.2.4.2. Monosaccharides
12.2.4.3. Oligosaccharides
12.2.4.4. Others
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Diagnostics
12.3.2. Drug Discovery & Development
12.3.3. Oncology
12.3.4. Immunology
12.3.5. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Academic Research Institute
12.4.2. Pharmaceutical & Biotechnology Companies
12.4.3. Contract Research Organizations
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Glycomics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Enzymes
13.2.1.1. Glycosidases
13.2.1.2. Glycosyltransferases
13.2.1.3. Neuraminidases
13.2.1.4. Sialyltransferases
13.2.1.5. Others
13.2.2. Instruments
13.2.2.1. Antibody Arrays
13.2.2.2. HPLC
13.2.2.3. Lectin Arrays
13.2.2.4. MALDI-TOF
13.2.2.5. Other Glycomics Instruments
13.2.3. Kits
13.2.3.1. Glycan Labeling Kits
13.2.3.2. Glycan Purification Kits
13.2.3.3. Glycan Release Kits
13.2.3.4. Others
13.2.4. Reagents
13.2.4.1. Glycoproteins
13.2.4.2. Monosaccharides
13.2.4.3. Oligosaccharides
13.2.4.4. Others
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Diagnostics
13.3.2. Drug Discovery & Development
13.3.3. Oncology
13.3.4. Immunology
13.3.5. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Academic Research Institute
13.4.2. Pharmaceutical & Biotechnology Companies
13.4.3. Contract Research Organizations
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Glycomics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Enzymes
14.2.1.1. Glycosidases
14.2.1.2. Glycosyltransferases
14.2.1.3. Neuraminidases
14.2.1.4. Sialyltransferases
14.2.1.5. Others
14.2.2. Instruments
14.2.2.1. Antibody Arrays
14.2.2.2. HPLC
14.2.2.3. Lectin Arrays
14.2.2.4. MALDI-TOF
14.2.2.5. Other Glycomics Instruments
14.2.3. Kits
14.2.3.1. Glycan Labeling Kits
14.2.3.2. Glycan Purification Kits
14.2.3.3. Glycan Release Kits
14.2.3.4. Others
14.2.4. Reagents
14.2.4.1. Glycoproteins
14.2.4.2. Monosaccharides
14.2.4.3. Oligosaccharides
14.2.4.4. Others
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Diagnostics
14.3.2. Drug Discovery & Development
14.3.3. Oncology
14.3.4. Immunology
14.3.5. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Academic Research Institute
14.4.2. Pharmaceutical & Biotechnology Companies
14.4.3. Contract Research Organizations
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix
15.2. Market Share Analysis, by Company, 2020
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. Agilent Technologies, Inc.
15.4.1.1. Company Description
15.4.1.2. Business Overview
15.4.1.3. Financial Overview
15.4.1.4. SWOT Analysis
15.4.2. Asparia Glycomics
15.4.2.1. Company Description
15.4.2.2. SWOT Analysis
15.4.3. Bruker Corporation
15.4.3.1. Company Description
15.4.3.2. Business Overview
15.4.3.3. Financial Overview
15.4.3.4. SWOT Analysis
15.4.4. Canadian Glycomics Network (GLYCONET)
15.4.4.1. Company Description
15.4.4.2. Business Overview
15.4.4.3. SWOT Analysis
15.4.5. Glyco Expression Technologies, Inc.
15.4.5.1. Company Description
15.4.5.2. SWOT Analysis
15.4.6. Glycodiag
15.4.6.1. Company Description
15.4.6.2. Business Overview
15.4.6.3. SWOT Analysis
15.4.7. Merck KGaA
15.4.7.1. Company Description
15.4.7.2. Business Overview
15.4.7.3. Financial Overview
15.4.7.4. SWOT Analysis
15.4.8. New England Biolabs
15.4.8.1. Company Description
15.4.8.2. Business Overview
15.4.8.3. SWOT Analysis
15.4.9. RayBiotech, Inc.
15.4.9.1. Company Description
15.4.9.2. SWOT Analysis
15.4.10. Shimadzu Corporation
15.4.10.1. Company Description
15.4.10.2. Business Overview
15.4.10.3. Financial Overview
15.4.10.4. SWOT Analysis
15.4.11. Thermo Fisher Scientific, Inc.
15.4.11.1. Company Description
15.4.11.2. Business Overview
15.4.11.3. Financial Overview
15.4.11.4. SWOT Analysis
15.4.12. Vector Laboratories
15.4.12.1. Company Description
15.4.12.2. Business Overview
15.4.12.3. SWOT Analysis
15.4.13. Glyde Bio, Inc.
15.4.13.1. Company Description
15.4.13.2. SWOT Analysis

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(薬学的薬物)の最新刊レポート

Transparency Market Research社のその他分野での最新刊レポート

  • 最新刊レポートはありません。

よくあるご質問


Transparency Market Research社はどのような調査会社ですか?


トレンスペアレンシーマーケットリサーチ(Transparency Market Research /TMR)は市場参入やホワイトスペースの特定、新商品や新サービスの立ち上げ、戦略的M&Aなどの実現のた... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る